Globe and Mail reports on death of Zambian HIV/AIDS advocate Winstone Zulu

Toronto's Globe and Mail reports on the death on Thursday of Winstone Zulu, an HIV/AIDS advocate from Zambia who lived with the virus for two decades. "His death has devastated the international community of AIDS activists," the newspaper writes, adding, "Winstone was a one-man force who played a key role in reshaping the global response to HIV/AIDS and [tuberculosis (TB)]. He personally lobbied every G8 leader; he spoke to mass rallies on five continents; he inspired audiences at schools and in churches and in parliaments in dozens of countries."

The newspaper outlines some of Winstone's achievements, including assisting in the 1994 drafting of the Paris Declaration, which enshrined the idea of legal protection from discrimination for people with HIV; taking part in the 1996 meeting in Como, Italy, at which UNAIDS was founded; and helping "to organize what was perhaps the most seminal AIDS gathering of the past 25 years: the 1996 conference in Vancouver where David Ho announced that he had successfully suppressed HIV using a cocktail of antiretroviral (ARV) drugs" (Nolen, 10/14).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    New HIV prevention injection offers 96% protection